Key result
Combined lncRNAs N1LR and SNHG1 yield an AUC of ~0.96 for diagnosing AMI.
Why the study?
Current biomarkers for acute myocardial infarction have inherent limitations, necessitating research into novel biomarkers for accurate and quick diagnosis.
Do lncRNAs N1LR and SNHG1 have diagnostic value for acute myocardial infarction?
Population
148 AMI patients and 50 healthy volunteers
Comparison
AMI patients vs healthy volunteers
Design
Case-control study
Authors
Loading...
Supports diagnostic potential of lncRNA panel in AMI but should not change practice; leaves open need for prospective validation.
Case-Control (n=198)
No
Do lncRNAs N1LR and SNHG1 have diagnostic value for acute myocardial infarction?
Effect estimate: AUC 0.962 (95% CI 0.933-0.991)
The long non-coding RNAs N1LR and SNHG1 show potential as novel diagnostic biomarkers for acute myocardial infarction.
Zhu et al. (2023) conducted a case-control in Acute myocardial infarction (n=198). lncRNA N1LR and SNHG1 levels vs. Healthy volunteers was evaluated on Diagnostic accuracy (AUC) of combined N1LR and SNHG1 for acute myocardial infarction (AUC 0.962, 95% CI 0.933-0.991). The combination of lncRNAs N1LR and SNHG1 demonstrated high diagnostic accuracy for acute myocardial infarction, yielding an area under the curve of 0.962.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: